Stability study of sodium colistimethate-loaded lipid nanoparticles

References

• Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: Formulation, process and storage considerations. Adv Drug Deliv Rev, 2006;58:1688–713.
   PubMed Web of Science ®Google Scholar
• Alipour M, Halwani M, Omri A, Suntres ZE. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains. Int J Pharm, 2008;355:293–8.
   PubMed Web of Science ®Google Scholar
• Beaulac C, Clement-Major S, Hawari J, Lagace J. In vitro kinetics of drug release and pulmonary retention of microencapsulated antibiotic in liposomal formulations in relation to the lipid composition. J Microencapsul, 1997;14:335–48.
   PubMed Web of Science ®Google Scholar
• Cavalli R, Caputo O, Carlotti ME, Trotta M, Scarnecchia C, Gasco MR. Sterilisation and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles. Int J Pharm, 1997;148:47–54.
   Web of Science ®Google Scholar
• Chacon M, Molpeceres J, Berges L, Guzman M, Aberturas MR. Stability and freeze-drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers. Eur J Pharm Sci, 1999;8:99–107.
   PubMed Web of Science ®Google Scholar
• Chen C, Tsai T, Huang Z, Fang J. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: Physicochemical characterisation and pharmacokinetics. Eur J Pharm Biopharm, 2010;74:474–82.
   PubMed Web of Science ®Google Scholar
• Chono S, Tanino T, Seki T, Morimoto K. Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes. J Drug Target, 2006;14:557–66.
   PubMed Web of Science ®Google Scholar
• Crowe LM, Reid DS, Crowe JH. Is trehalose special for preserving dry biomaterials? Biophys J, 1996;71:2087–93.
   PubMed Web of Science ®Google Scholar
• Das S, Chaudhury A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech, 2011;12:62–76.
   PubMed Web of Science ®Google Scholar
• Das S, Ng WK, Tan RB. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterisations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci, 2012;47:139–51.
   PubMed Web of Science ®Google Scholar
• del Pozo-Rodriguez A, Solinis MA, Gascon AR, Pedraz JL. Short- and long-term stability study of lyophilised solid lipid nanoparticles for gene therapy. Eur J Pharm Biopharm, 2009;71:181–9.
   PubMed Web of Science ®Google Scholar
• Dijkmans AC, Wilms EB, Kamerling IM, Birkhoff W, Ortiz-Zacarias NV, van Nieuwkoop C, Verbrugh HA, Touw DJ. Colistin: Revival of an old polymyxin antibiotic. Ther Drug Monit, 2014;37:419–27.
   Web of Science ®Google Scholar
• Falagas ME, Kasiakou SK. Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis, 2005;40:1333–41.
   PubMed Web of Science ®Google Scholar
• Freitas C, Müller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions. Int J Pharm, 1998;168:221–9
   Web of Science ®Google Scholar
• Gainza G, Aguirre JJ, Pedraz JL, Hernández RM, Igartua M. rhEGF-loaded PLGA-Alginate microspheres enhance the healing of full-thickness excisional wounds in diabetised Wistar rats. Eur J Pharm Sci, 2013;50:243–52.
   PubMed Web of Science ®Google Scholar
• Gartziandia O, Herran E, Pedraz JL, Carro E, Igartua M, Hernandez RM. Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration. Colloids Surf B Biointerfaces, 2015;134:304–13.
   PubMed Web of Science ®Google Scholar
• Ghaffari S, Varshosaz J, Saadat A, Atyabi F. Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles. Int J Nanomedicine, 2011;6:35–43.
   Web of Science ®Google Scholar
• Grimm W. Extension of the International Conference on Harmonisation Tripartite Guideline for Stability Testing of New Drug Substances and Products to countries of climatic zones III and IV. Drug Dev Ind Pharm, 1998;24:313–25.
   PubMed Web of Science ®Google Scholar
• Guideline ICH. 2003. Stability testing of new drug substances and products. Q1A (R2) [online]. Geneva, Switzerland: International Conference on Harmonization. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2__Guideline.pdf
   Google Scholar
• Haskell R, Shifflett J, Elzinga P. 1998. Particle-sizing technologies for submicron emulsions. Submicron emulsions in drug targeting and delivery. Amsterdam: Harwood Academic Publishers.
   Google Scholar
• Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP. Physico-chemical stability of colloidal lipid particles. Biomaterials, 2003;24:4283–300.
   PubMed Web of Science ®Google Scholar
• Hu F, Jiang S, Du Y, Yuan H, Ye Y, Zeng S. Preparation and characteristics of monostearin nanostructured lipid carriers. Int J Pharm, 2006;314:83–9.
   PubMed Web of Science ®Google Scholar
• Huh AJ, Kwon YJ. “Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J. Control Release, 2011;156:128–45.
   PubMed Web of Science ®Google Scholar
• Jennings TA. 1999. Lyophilisation: Introduction and basic principles. Boca Raton, FL: CRC Press.
   Google Scholar
• Kaur S, Nautyal U, Singh R, Singh S, Devi A. Nanostructure Lipid Carrier (NLC): The new generation of lipid nanoparticles. Asian Pac J Health Sci, 2015;2:76–93.
   Google Scholar
• Kim J, Park J, Kim C. Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release. Int J Pharm, 2010;383:209–15.
   PubMed Web of Science ®Google Scholar
• Misra R, Acharya S, Dilnawaz F, Sahoo SK. Sustained antibacterial activity of doxycycline-loaded poly (D, L-lactide-co-glycolide) and poly (ɛ-caprolactone) nanoparticles. Nanomedicine, 2009;4:519–30.
   PubMed Web of Science ®Google Scholar
• Molina M, Armstrong TK, Zhang Y, Patel MM, Lentz YK, Anchordoquy TJ. The stability of lyophilized lipid/DNA complexes during prolonged storage. J Pharm Sci, 2004;93:2259–73.
   PubMed Web of Science ®Google Scholar
• Moreno-Sastre M, Pastor M, Salomon CJ, Esquisabel A, Pedraz JL. Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy. J Antimicrob Chemother, 2015;70:2945–55.
   PubMed Web of Science ®Google Scholar
• Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – A review of the state of the art. Eur J Pharm Biopharm, 2000;50:161–77.
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing S. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm, 2002;242:121–8.
   PubMed Web of Science ®Google Scholar
• Muller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev, 2007;59:522–30.
   PubMed Web of Science ®Google Scholar
• Omri A, Suntres ZE, Shek PN. Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem Pharmacol, 2002;64:1407–13.
   PubMed Web of Science ®Google Scholar
• Pardeike J, Weber S, Haber T, Wagner J, Zarfl HP, Plank H, Zimmer A. Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application. Int J Pharm, 2011;419:329–38.
   PubMed Web of Science ®Google Scholar
• Pastor M, Moreno-Sastre M, Esquisabel A, Sans E, Viñas M, Bachiller D, Asensio VJ, Pozo ÁD, Gainza E, Pedraz JL. Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis. Int J Pharm, 2014;477:485–94.
   PubMed Web of Science ®Google Scholar
• Radomska-Soukharev A. Stability of lipid excipients in solid lipid nanoparticles. Adv Drug Deliv Rev, 2007;59:411–18.
   PubMed Web of Science ®Google Scholar
• Ridolfi DM, Marcato PD, Justo GZ, Cordi L, Machado D, Durán N. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin. Colloids Surf B Biointerfaces, 2012;93:36–40.
   PubMed Web of Science ®Google Scholar
• Sanjula B, Shah FM, Javed A, Alka A. Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement. J Drug Target, 2009;17:249–56.
   PubMed Web of Science ®Google Scholar
• Schwarz C, Mehnert W. Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int J Pharm, 1997;157:171–9.
   PubMed Web of Science ®Google Scholar
• Solleti VS, Alhariri M, Halwani M, Omri A. Antimicrobial properties of liposomal azithromycin for Pseudomonas infections in cystic fibrosis patients. J Antimicrob Chemother, 2015;70:784–96.
   PubMed Web of Science ®Google Scholar
• Suk JS, Lai SK, Wang YY, Ensign LM, Zeitlin PL, Boyle MP, Hanes J. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. Biomaterials, 2009;30:2591–7.
   PubMed Web of Science ®Google Scholar
• Uner M. Preparation, characterisation and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): Their benefits as colloidal drug carrier systems. Pharmazie, 2006;61:375–86.
   PubMed Web of Science ®Google Scholar
• Venkateswarlu V, Manjunath K. Preparation, characterisation and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release, 2004;95:627–38.
   PubMed Web of Science ®Google Scholar
• Vivek K, Reddy H, Murthy RSR. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS PharmSciTech, 2007;8:E1–9.
   PubMed Web of Science ®Google Scholar
• Weber S, Zimmer A, Pardeike J. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: A review of the state of the art. Eur J Pharm Biopharm, 2014;86:7–22.
   PubMed Web of Science ®Google Scholar
• Wissing SA, Kayser O, Müller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev, 2004;56:1257–72.
   PubMed Web of Science ®Google Scholar
• Yang W, Peters JI, Williams RO. 3rd, Inhaled nanoparticles – A current review. Int J Pharm, 2008;356:239–47.
   PubMed Web of Science ®Google Scholar
• Zhang J, Fan Y, Smith E. Experimental design for the optimization of lipid nanoparticles. J Pharm Sci, 2009;98:1813–19.
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhou D. Improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers. Drug Des Devel Ther, 2015;9:5269.
   PubMed Web of Science ®Google Scholar
• Zimmermann E, Müller RH, Mäder K. Influence of different parameters on reconstitution of lyophilized SLN. Int J Pharm, 2000;196:211–13.
   PubMed Web of Science ®Google Scholar